Navigating the expanded access investigational new drug protocol for tecovirimat: lessons learned from a public-private hospital partnership during the 2022 NYC mpox outbreak.

Mgbako, Ofole; Chan, Justin; Pitts, Robert A; DiLorenzo, Madeline A; Knutsen, Dorothy; Mazo, Dana

Mgbako, Ofole; Chan, Justin; Pitts, Robert A; DiLorenzo, Madeline A; Knutsen, Dorothy; Mazo, Dana.

Afiliação

Mgbako O; Division of Infectious Diseases and Immunology, Department of Medicine, NYU Langone Health, New York, NY, USA.
Chan J; Division of Infectious Diseases, Department of Medicine, New York City Health + Hospitals/Bellevue, New York, NY, USA.
Pitts RA; Division of Infectious Diseases and Immunology, Department of Medicine, NYU Langone Health, New York, NY, USA.
DiLorenzo MA; Division of Infectious Diseases, Department of Medicine, New York City Health + Hospitals/Bellevue, New York, NY, USA.
Knutsen D; Division of Infectious Diseases and Immunology, Department of Medicine, NYU Langone Health, New York, NY, USA.
Mazo D; Division of Infectious Diseases, Department of Medicine, New York City Health + Hospitals/Bellevue, New York, NY, USA.

Antimicrob Steward Healthc Epidemiol ; 3(1): e110, 2023.

Article em En | MEDLINE | ID: mdl-37502253

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Antimicrob Steward Healthc Epidemiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google